COMMUNIQUÉS West-GlobeNewswire

-
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
21/05/2025 -
Assemblée Générale Mixte du 21 mai 2025
21/05/2025 -
Combined General Meeting of May 21, 2025
21/05/2025 -
OSE Immunotherapeutics annonce une collaboration stratégique sur des technologies pionnières dans le domaine de l’ARNm
21/05/2025 -
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies
21/05/2025 -
Ipsen S.A. - Assemblée Générale Annuelle du 21 mai 2025
21/05/2025 -
Ipsen S.A. - Annual General Meeting held on 21 May 2025
21/05/2025 -
Joule Health & Wellbeing Offers Same-Day Stress Support, Providing a Scalable Solution for HR Leaders Addressing Burnout
21/05/2025 -
Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
21/05/2025 -
Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences
21/05/2025 -
All Three Leading Proxy Advisory Firms – ISS, Glass Lewis, and Egan-Jones – Recommend Zevra Stockholders Vote FOR the Company’s Director Nominees
21/05/2025 -
Soleno Therapeutics to Participate in Upcoming June Conferences
21/05/2025 -
The Beauty Health Company Announces Convertible Debt Refinancing
21/05/2025 -
Galimedix Therapeutics publishes new data in peer-reviewed International Journal of Molecular Sciences demonstrating disease-modifying capability of GAL-201 in Alzheimer’s disease
21/05/2025 -
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
21/05/2025 -
Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101
21/05/2025 -
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025
21/05/2025 -
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
21/05/2025 -
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
21/05/2025
Pages